Enzyme immunoassay for the quantitative determination of antibodies to Bevacizumab (Avastin®) in serum and plasma with confirmation.
This kit has been especially developed for the quantitative antibodies to Bevacizumab in serum and plasma samples
Bevacizumab (Avastin®) was associated to the development of anti-bevacizumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Avastin®.This might lead to severe complications. This kit can be efficiently used for monitoring anti- bevacizumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-bevacizumab antibodies.
All SHIKARI® ELISA kits are suitable for biosimilar work.
